-
公开(公告)号:US06448258B2
公开(公告)日:2002-09-10
申请号:US09836660
申请日:2001-04-17
IPC分类号: A61K314745
CPC分类号: A61K31/445 , A61K31/451 , A61K31/4745 , A61K31/48
摘要: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds or a salt of any said compound.
摘要翻译: 本发明提供了通过施用杂环胺型化合物或任何所述化合物的盐来治疗纤维肌痛综合征或慢性疲劳综合征的方法。
-
2.
公开(公告)号:US06555548B2
公开(公告)日:2003-04-29
申请号:US10159913
申请日:2002-05-30
IPC分类号: A61K31437
CPC分类号: A61K31/445 , A61K31/451 , A61K31/4745 , A61K31/48
摘要: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of cabergoline-type compounds or a salt of said compound.
摘要翻译: 本发明提供了通过给予卡麦角林型化合物或所述化合物的盐来治疗纤维肌痛综合征或慢性疲劳综合征的方法。
-
公开(公告)号:US06410579B1
公开(公告)日:2002-06-25
申请号:US09783656
申请日:2001-02-14
IPC分类号: A61K31425
摘要: This patent application describes the treatment addictive disorders, psychoactive substance use disorders, intoxication disorders, inhalation disorders, alcohol addiction, tobacco addiction and or nicotine addiction comprising administering a therapeutically effective, nontoxic dose of pramipexole and derivatives and or pharmaceutically acceptable salts thereof to a patient.
-
公开(公告)号:US07317011B2
公开(公告)日:2008-01-08
申请号:US10758864
申请日:2004-01-16
申请人: Erik H. F. Wong , Saeeduddin Ahmed , Robert Clyde Marshall , Robert McArthur , Duncan P. Taylor
发明人: Erik H. F. Wong , Saeeduddin Ahmed , Robert Clyde Marshall , Robert McArthur , Duncan P. Taylor
IPC分类号: A61K31/535 , A61K31/537
CPC分类号: A61K31/5375 , A61K31/00 , A61K31/537
摘要: Disclosed herein are methods of treating an individual suffering from peripheral neuropathy. The methods generally include administration of a therapeutic amount of optically pure (S,S) reboxetine, or a pharmaceutically acceptable salt thereof. Embodiments of these methods can diminish adverse side effects.
摘要翻译: 本文公开了治疗患有周围神经病变的个体的方法。 所述方法通常包括施用治疗量的光学纯的(S,S)瑞波西汀或其药学上可接受的盐。 这些方法的实施方案可以减少不利的副作用。
-
-
-